Applied Historical Balance Sheet
APLT Stock | USD 1.24 0.03 2.48% |
Trend analysis of Applied Therapeutics balance sheet accounts such as Other Current Liab of 71.3 M, Total Current Liabilities of 74.7 M or Other Liab of 0.0 provides information on Applied Therapeutics' total assets, liabilities, and equity, which is the actual value of Applied Therapeutics to its prevalent stockholders. By breaking down trends over time using Applied Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Applied Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Applied Therapeutics is a good buy for the upcoming year.
Applied Therapeutics Inventory |
|
Applied |
About Applied Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Applied Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Applied Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Applied Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Applied currently owns. An asset can also be divided into two categories, current and non-current.
Applied Therapeutics Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Applied Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Applied Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Applied Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Applied Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Accounts Payable
An accounting item on the balance sheet that represents Applied Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Applied Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most accounts from Applied Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Applied Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.At this time, Applied Therapeutics' Non Current Liabilities Total is comparatively stable compared to the past year. Capital Surpluse is likely to gain to about 293.2 M in 2024, despite the fact that Retained Earnings are likely to grow to (445.2 M).
2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 16.1M | 27.9M | 67.9M | 71.3M | Total Assets | 89.9M | 38.4M | 54.8M | 56.5M |
Applied Therapeutics balance sheet Correlations
Click cells to compare fundamentals
Applied Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Applied Therapeutics balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 48.4M | 104.5M | 89.9M | 38.4M | 54.8M | 56.5M | |
Other Current Liab | 264K | 19.8M | 16.1M | 27.9M | 67.9M | 71.3M | |
Total Current Liabilities | 14.1M | 21.2M | 26.5M | 33.4M | 71.2M | 74.7M | |
Total Stockholder Equity | 32.6M | 81.9M | 62.5M | 4.1M | (17.1M) | (16.3M) | |
Net Tangible Assets | (19.6M) | 32.6M | 81.9M | 62.5M | 71.9M | 75.5M | |
Net Debt | (16.8M) | (55.7M) | (52.6M) | (15.8M) | (49.1M) | (46.7M) | |
Retained Earnings | (66.8M) | (160.7M) | (266.3M) | (348.8M) | (468.6M) | (445.2M) | |
Accounts Payable | 8.8M | 640K | 9.5M | 4.5M | 1.7M | 1.7M | |
Cash | 18.9M | 57.5M | 53.9M | 16.7M | 49.9M | 34.4M | |
Non Current Assets Total | 2.2M | 1.9M | 1.5M | 1.1M | 447K | 424.7K | |
Other Assets | 199K | 1.9M | 200K | 1.0 | 1.15 | 1.09 | |
Cash And Short Term Investments | 38.9M | 96.8M | 80.8M | 30.6M | 49.9M | 50.1M | |
Common Stock Shares Outstanding | 12.8M | 22.0M | 25.6M | 37.8M | 84.2M | 88.5M | |
Liabilities And Stockholders Equity | 48.4M | 104.5M | 89.9M | 38.4M | 54.8M | 56.5M | |
Non Current Liabilities Total | 1.7M | 1.3M | 891K | 878K | 797K | 1.4M | |
Other Current Assets | 7.3M | 5.3M | 7.0M | 6.5M | 4.2M | 5.0M | |
Other Stockholder Equity | 51.0M | 242.8M | 329.0M | 352.8M | 451.4M | 230.2M | |
Total Liab | 15.8M | 22.6M | 27.4M | 34.3M | 72.0M | 75.6M | |
Net Invested Capital | 32.6M | 83.0M | 63.3M | 5.1M | (16.8M) | (16.0M) | |
Total Current Assets | 46.2M | 102.6M | 88.4M | 37.3M | 54.4M | 55.4M | |
Accumulated Other Comprehensive Income | (2K) | (112K) | (107K) | 51K | 45.9K | 48.2K | |
Net Working Capital | 32.1M | 81.4M | 61.9M | 3.9M | (16.8M) | (16.0M) | |
Short Term Debt | 356K | 812K | 884K | 954K | 858K | 607.2K | |
Common Stock | 1K | 2K | 3K | 5K | 8K | 8.4K | |
Capital Stock | 1K | 2K | 3K | 5K | 8K | 8.4K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Applied Stock Analysis
When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.